Contrast-Enhanced Dynamic MR Imaging of Uterine Fibroids as a Potential Predictor of Patient Eligibility for MR Guided Focused Ultrasound (MRgFUS) Treatment for Symptomatic Uterine Fibroids
Figure 2
Contrast-enhanced sagittal T1-weighted screening MR dynamic images acquired at 30, 60, and 90 seconds post contrast injection (from left to right). Fibroid shows lower enhancement than the myometrium in the first 2 minutes postinjection.
